Microparticles and cancer thrombosis in animal models

Thrombosis Research

Volumn 140, Issue , 2016, Pages S21-S26

  Mege, Diane ^a   Mezouar, Soraya ^a   Dignat George, Françoise ^a,b   Panicot Dubois, Laurence ^a   Dubois, Christophe ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Animal model; Cancer; Microparticle; Thrombosis; Tissue factor

Indexed keywords

PHOSPHATIDYLSERINE; THROMBIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CANCER GROWTH; CARCINOGENESIS; EXPERIMENTAL METASTASIS; MEMBRANE MICROPARTICLE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; THROMBOCYTOSIS; TUMOR THROMBUS; VENOUS THROMBOEMBOLISM; ANIMAL; BLOOD; COMPLICATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; HUMAN; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; PATHOLOGY; RISK FACTOR; THROMBOSIS;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; THROMBOPLASTIN; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84962713662     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(16)30094-9     Document Type: Article

References (41)

1. M. Ouaissi, C. Frasconi, D. Mege, L. Panicot-Dubois, L. Boiron, L. Dahan, and et al. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma HBPD INT. 14 2015 436 442
2. Y. Hisada, J.E. Geddings, C. Ay, and N. Mackman Venous thrombosis and cancer: from mouse models to clinical trials J. Thromb. Haemost. 13 2015 1372 1382
3. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch. Intern. Med. 166 2006 458 464
4. J.F. Timp, S.K. Braekkan, H.H. Versteeg, and S.C. Cannegieter Epidemiology of cancer-associated venous thrombosis Blood. 122 2013 1712 1723
5. H.T. Sørensen, L. Mellemkjaer, F.H. Steffensen, J.H. Olsen, and G.L. Nielsen The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism N. Engl. J. Med. 338 1998 1169 1173
6. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc. Natl. Acad. Sci. 61 1968 46 52
7. E. Sierko, and M.Z. Wojtukiewicz Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin. Thromb. Hemost. 33 2007 712 721
8. V.Y. Bogdanov, V. Balasubramanian, J. Hathcock, O. Vele, M. Lieb, and Y. Nemerson Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein Nat. Med. 9 2003 458 462
9. N.S. Callander, N. Varki, and L.V. Rao Immunohistochemical identification of tissue factor in solid tumors Cancer. 70 1992 1194 1201
10. B.M. Mueller, R.A. Reisfeld, T.S. Edgington, and W. Ruf Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis Proc. Natl. Acad. Sci. 89 1992 11832 11836
11. G.M. Thomas, L. Panicot-Dubois, R. Lacroix, F. Dignat-George, D. Lombardo, and C. Dubois Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo J. Exp. Med. 206 2009 1913 1927
12. A.A. Khorana, C.W. Francis, K.E. Menzies, J.-G. Wang, O. Hyrien, J. Hathcock, and et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J. Thromb. Haemost. 6 2008 1983 1985
13. W. Ruf, E.G. Fischer, H.Y. Huang, Y. Miyagi, I. Ott, M. Riewald, and et al. Diverse functions of protease receptor tissue factor in inflammation and metastasis Immunol. Res. 21 2000 289 292
14. S. Mezouar, D. Mege, R. Darbousset, D. Farge, P. Debourdeau, F. Dignat-George, and et al. Involvement of platelet-derived microparticles in tumor progression and thrombosis Semin. Oncol. 41 2014 346 358
15. A. Piccin, W.G. Murphy, and O.P. Smith Circulating microparticles: pathophysiology and clinical implications Blood Rev. 21 2007 157 171
16. N.S. Barteneva, E. Fasler-Kan, M. Bernimoulin, J.N.H. Stern, E.D. Ponomarev, L. Duckett, and et al. Circulating microparticles: square the circle BMC Cell Biol. 14 2013 23
17. D. Mege, L. Panicot-Dubois, M. Ouaissi, S. Robert, I. Sielezneff, B. Sastre, and et al. The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study Int. J. Cancer. 2015
18. R. Lacroix, and F. Dignat-George Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation Thromb. Res. 129 Suppl 2 2012 S27 S29
19. F.F. van Doormaal, A. Kleinjan, M. Di Nisio, H.R. Büller, and R. Nieuwland Cell-derived microvesicles and cancer Neth J Med. 67 2009 266 273
20. J. Rak Microparticles in cancer Semin. Thromb. Hemost. 36 2010 888 906
21. M. Davila, A. Amirkhosravi, E. Coll, H. Desai, L. Robles, J. Colon, and et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation J. Thromb. Haemost. 6 2008 1517 1524
22. J.-G. Wang, J.E. Geddings, M.M. Aleman, J.C. Cardenas, P. Chantrathammachart, J.C. Williams, and et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer Blood. 119 2012 5543 5552
23. S. Mezouar, R. Darbousset, F. Dignat-George, L. Panicot-Dubois, and C. Dubois Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo Int. J. Cancer. 136 2015 462 475
24. M. Demers, D.S. Krause, D. Schatzberg, K. Martinod, J.R. Voorhees, T.A. Fuchs, and et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis Proc. Natl. Acad. Sci. 109 2012 13076 13081
25. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, J. Bottsford-Miller, and et al. Paraneoplastic thrombocytosis in ovarian cancer N. Engl. J. Med. 366 2012 610 618
26. L.G. Lima, R. Chammas, R.Q. Monteiro, M.E.C. Moreira, and M.A. Barcinski Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner Cancer Lett. 283 2009 168 175
27. A.D.S. de Oliveira, L.G. Lima, A. Mariano-Oliveira, D.E. Machado, L.E. Nasciutti, J.F. Andersen, and et al. Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma Thromb. Res. 130 2012 e163 e170
28. A. Janowska-Wieczorek, M. Wysoczynski, J. Kijowski, L. Marquez-Curtis, B. Machalinski, J. Ratajczak, and et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int. J. Cancer. 113 2005 752 760
29. R. Seth, L.-H. Tai, T. Falls, C.T. de Souza, J.C. Bell, M. Carrier, and et al. Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model Ann. Surg. 258 2013 158 168
30. G. Sitia, R. Aiolfi, P. Di Lucia, M. Mainetti, A. Fiocchi, F. Mingozzi, and et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B Proc. Natl. Acad. Sci. 109 2012 E2165 E2172
31. P.B. Blair A new strain of the mouse mammary tumor virus Science. 127 1958 518
32. M.P. Holt, E.M. Shevach, and G.A. Punkosdy Endogenous mouse mammary tumor viruses (mtv): new roles for an old virus in cancer, infection, and immunity Front Oncol. 3 2013 287
33. C.A. Granville, N. Warfel, J. Tsurutani, M.C. Hollander, M. Robertson, S.D. Fox, and et al. Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors Clin. Cancer Res. 13 2007 2281 2289
34. M. Gilabert, E. Calvo, A. Airoldi, T. Hamidi, V. Moutardier, O. Turrini, and et al. Pancreatic cancer-induced cachexia is Jak2-dependent in mice J. Cell. Physiol. 229 2014 1437 1443
35. C.E. Cano, T. Hamidi, M.N. Garcia, D. Grasso, C. Loncle, S. Garcia, and et al. Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis Gut. 63 2014 984 995
36. R. Lacroix, C. Judicone, P. Poncelet, S. Robert, L. Arnaud, J. Sampol, and et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol J. Thromb. Haemost. 10 2012 437 446
37. E. Chargaff, and R. West The biological significance of the thromboplastic protein of blood J. Biol. Chem. 166 1946 189 197
38. Z. Mallat, H. Benamer, B. Hugel, J. Benessiano, P.G. Steg, J.M. Freyssinet, and et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes Circulation. 101 2000 841 843
39. E. Campello, L. Spiezia, C.M. Radu, C. Bulato, M. Castelli, S. Gavasso, and et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism Thromb. Res. 127 2011 473 477
40. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J.I. Weitz, and et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood. 105 2005 1734 1741
41. M. Ikeda, S. ichi Iwamoto, H. Imamura, H. Furukawa, and T. Kawasaki Increased platelet aggregation and production of platelet-derived microparticles after surgery for upper gastrointestinal malignancy J. Surg. Res. 115 2003 174 183